Table 3.

Number of Patients Reporting Treatment-Emergent Adverse Events During the Study

Adverse Event	Milnacipran, n (%)a	Placebo, n (%)a
Depression	2 (10)	2 (10)
Insomnia	2 (10)	6 (30)
Tiredness	0	1 (5)
Pain	1 (5)	4 (20)
Dizziness	1 (5)	2 (10)
Restlessness	0	1 (5)
Dry mouth	0	2 (10)
Nausea	3 (15)	1 (5)
Diarrhea	0	1 (5)
Appetite change	1 (5)	1 (5)
Urinary difficulty	1 (5)	0
Itching	1 (5)	0

^aN = 20.